Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more

DRUG MARKETING

Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.

Drug Marketing is part of Business Exchange, suggested by Arlene Weintraub. This topic contains 408 news and 218 blog items. Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from like-minded professionals.

Most Active

The most active stories in this topic based on user activity.

Congress Mulls Scrapping Tax Break for Pharma Adsmore

Congress is considering a $37 billion proposal that would deny pharmaceutical companies from taking tax deductions on...

Drug Firms Jockey for Space Onlinemore

A growing number of drug firms are trying their luck with social media tools such as Facebook and Twitter.

Generic Biotech Drugs: Cure or Quagmire?more

When President Barack Obama spoke to the American Medical Assn. on June 15, he couldn't quite quantify the potential...

FDA Panel Recommends Psych Drugs for Kidsmore

An advisory panel of the Food and Drug Administration said two leading antipsychotic medications should be approved for...

FTC: 12-14 yrs too long to protect biotech drugsmore

Generic versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United...

Mental Illness Becomes Big Target for Pharma, with 301 New Drugs in De...more

Pharmaceutical industry report tallies the number of drugs in development, along with descriptions of each.

Study gauges effect of drugmakers' ads more

A spike in interest in the drug Zelnorm did little to boost prescriptions.

Loophole Exposes Canadians To Drug Ads Banned In US more

Despite a ban on direct-to-consumer drug advertising in their country, Canadians have been exposed to more than $90...

Forest Reserves $170 Million for Settlementmore

Forest Laboratories recently set aside $170 million in anticipation of eventually settling a federal government...

Romancing the Enemy Pays Off for Drug Companiesmore

Big pharma is using coopetition and lawsuits as tactics to corner market and boost shareholder value.

Physicians discuss concerns about device DTC advertising with US lawma...more

Cardiologists advise the FDA on direct-to-consumer advertising.

Pharma could shed negative image if they get involved in Web 2.0more

In recent article published by Ad Week, they take a look at the current image of big Pharma companies.

Game Over: FDA Cracks Down on Viagra Online Pushmore

campaign with a single letter, so companies have taken the most conservative route possible. The FDA's Division of Drug...

Top Pharma Contributors to Federal Candidates and Partiesmore

...preferred by the pharmaceutical ... to be quoted in a Pharma Marketing News

Merck Makes Phony Peer-Review Journalmore

It's a safe guess that somewhere at Merck today someone is going through the meeting minutes of the day that the...

Study Casts Doubt on Value of Direct-to-Consumer Drug Adsmore

Prescription Sales Found to Be Barely Affected in the Long Run

Is Cost Containment Impacting Pharmaceutical Innovation?more

With the costs of providing healthcare spiraling, governments and payers across the seven major markets are...

Drug Lobby Spends $1 Billionmore

The drug lobby spent $168 million in 2007, up 32% from the year before.

Key opinion leaders: independent experts or drug representatives in di...more

Ray Moynihan examines the role of the influential experts paid by industry to help "educate" the profession...

FDA Advisors Face Conflict Capmore

FDA is tightening up its conflict-of-interest rules for expert advisory panels that often weigh in on contentious drug...

Restrict drug ads?more

A University of Georgia professor weighs in on the idea of banning direct-to-consumer advertising.

Europe Moves to Loosen Ban Against Drug Adsmore

European officials moved one step closer to allowing drug companies to publish information about prescription medicines...

Pencils, Paper and Pills: Are ADHD Drug Ads Too Much?more

Extract not available.

U.S. FDA staff backs Lilly, Daiichi anti-clot drug | Markets | Markets...more

WASHINGTON, Jan 30 (Reuters) - U.S. regulatory staff recommended approval of Eli Lilly and Co's (LLY.N) and Daiichi...

Bitter Pillmore

Created to treat schizophrenia, Zyprexa wound up being used on misbehaving kids. How the pharmaceutical industry turned...

Topic Feed: Most active content in Drug Marketing

Top Sources: Drug Marketing

  • Reuters
  • New York Times
  • adage.com
  • Wall Street Journal Online
  • Forbes.com
  • jpost.com
  • MarketWatch
  • online.wsj.com
  • bloomberg.com
  • money.cnn.com

Most Active Users in this Topic

see all contributors in Drug Marketing

Featured White Papers

Post a Job

Jobs in this Topic

Account Supervisor Shopper Marketing Advantage Sales & Marketing | Englewood Cliffs, NJ
Posted: May 18
Pharma Senior Finance Effectiveness PwC | Hartford, CT
Posted: May 17
Delivery Driver-AD Homesmart | Raleigh, NC
Posted: May 23
Digital Pharma Marketing - Advertising Roles T Scott International | New York, NY
Posted: May 11

Report comment contains invalid characters. ()
cancel
Search Cancel